Claire Vale
Overview
Explore the profile of Claire Vale including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
191
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gurusamy K, Leung J, Vale C, Roberts D, Linden A, Tan X, et al.
Health Technol Assess
. 2024 Sep;
28(51):1-139.
PMID: 39254852
Background: We compared the relative benefits, harms and cost-effectiveness of hyperthermic intraoperative peritoneal chemotherapy + cytoreductive surgery ± systemic chemotherapy versus cytoreductive surgery ± systemic chemotherapy or systemic chemotherapy alone...
2.
Vale C, Godolphin P, Fisher D, Horby P, Kosiborod M, Hochman J, et al.
Lancet Diabetes Endocrinol
. 2024 Sep;
12(10):735-747.
PMID: 39250923
Background: Sodium-glucose co-transporter-2 (SGLT2) inhibitors have been proposed as a potential treatment for adults hospitalised with COVID-19, due to their potential anti-inflammatory and endothelial protective effects. Published evidence from randomised...
3.
Gurusamy K, Leung J, Vale C, Roberts D, Linden A, Tan X, et al.
World J Surg
. 2024 Apr;
48(6):1385-1403.
PMID: 38658171
Background: There is uncertainty in the relative benefits and harms of hyperthermic intraoperative peritoneal chemotherapy (HIPEC) when added to cytoreductive surgery (CRS) +/- systemic chemotherapy or systemic chemotherapy alone in...
4.
Fisher D, Burdett S, Vale C, White I, Tierney J
Syst Rev
. 2022 Dec;
11(1):274.
PMID: 36527153
Background: Research overlap and duplication is a recognised problem in the context of both pairwise and network systematic reviews and meta-analyses. As a case study, we carried out a scoping...
5.
Parker C, Sargos P, Sydes M, Kneebone A, Vale C
Lancet
. 2021 May;
397(10285):1624.
PMID: 33933204
No abstract available.
6.
Gafos M, South A, Hanley B, Brodnicki E, Hodson M, McCormack S, et al.
Res Involv Engagem
. 2020 Apr;
6:13.
PMID: 32322408
Background: The PROUD trial, a HIV prevention trial in men who have sex with men and trans women, set out to involve community representatives and trial participants in several ways....
7.
Vale C, Fisher D, Tierney J, White I, Sydes M, Carpenter J
Eur Urol
. 2017 Dec;
73(3):e49-e50.
PMID: 29233663
No abstract available.
8.
Kearney A, Williamson P, Young B, Bagley H, Gamble C, Denegri S, et al.
Health Expect
. 2017 Jun;
20(6):1401-1410.
PMID: 28618076
Background: Despite increasing international interest, there is a lack of evidence about the most efficient, effective and acceptable ways to implement patient and public involvement (PPI) in clinical trials. Objective:...
9.
Tierney J, Vale C, Riley R, Tudur Smith C, Stewart L, Clarke M, et al.
PLoS Med
. 2015 Jul;
12(7):e1001855.
PMID: 26196287
Jayne Tierney and colleagues offer guidance on how to spot a well-designed and well-conducted individual participant data meta-analysis.
10.
Sydes M, Vale C, Kneebone A, Pearse M, Richaud P, Tierney J, et al.
Eur Urol
. 2012 Sep;
62(6):e99.
PMID: 23018161
No abstract available.